InflammX Therapeutics, Inc. — Form D
InflammX Therapeutics, Inc. of TAMPA, FL, a company, filed a Form D exempt-offering notice with the SEC on 2022-05-23. Industry: Biotechnology.
Offering
- Filed: 2022-05-23
- Form: D
- Accession: 0001840051-22-000001
- Industry: Biotechnology
- Exemptions: 06b
- Investors: 2
- Date of first sale: 2022-05-06
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-446531
Issuer
- Name: InflammX Therapeutics, Inc.
- CIK: 0001840051
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 275 BAYSHORE BLVD, UNIT 1607, TAMPA, FL, 33606
- Phone: 858-480-2404
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| James Blair | Director | San Diego, CA |
| David Boyer | Director | Tampa, FL |
| Brian Levy | Director | Syosset, NY |
| Phil Rosenfeld | Director | Tampa, FL |
| Richard Rubino | Director | Boston, MA |
| Rajiv Shukla | Director | Pittsburgh, PA |
| Jason Werner | Director | Walpole, MA |
| Brian Levy | Executive Officer | Syosset, NY |
| David Pool | Executive Officer | San Diego, CA |
Other filings by this issuer (2)
More